Cloudbreak Therapeutics, LLC
6 clinical trials · Sponsor
◉ Watch Cloudbreak Therapeutics, LLC
| Record | Firm | Date |
|---|---|---|
| Safety and Efficacy Study of CBT-004 in Patients With Vascularized Pinguecula (NCT04884256) | Cloudbreak Therapeutics, LLC | 2023-12-21 |
| Safety, Tolerability and Pharmacodynamics Evaluation of CBT-009 Eye Drop (NCT05372991) | Cloudbreak Therapeutics, LLC | 2022-07-20 |
| A Clinical Trial on Safety and Efficacy of CBT-001 in Patients With Pterygium (NCT05456425) | Cloudbreak Therapeutics, LLC | 2022-06-30 |
| Safety, Efficacy and Pharmacokinetics of CBT-008 in Patients With Meibomian Gland Dysfunction (NCT05261386) | Cloudbreak Therapeutics, LLC | 2022-03-04 |
| Safety, Efficacy and Pharmacokinetics of CBT-006 in Patients With Meibomian Gland Dysfunction (NCT04884243) | Cloudbreak Therapeutics, LLC | 2021-09-05 |
Track Cloudbreak Therapeutics, LLC automatically
Every clearance here is in the API, with alerts when new ones post.